Creative Biostructure to Present at AACR Annual Meeting 2024 | April 5-10, 2024 | Booth #2953 
COVID-19 VLP (S; Null Protein)(CBS-V955)
Inquiry
| Product Summary | |
|---|---|
| Name | COVID-19 VLP (S; Null Protein) |
Download Datasheet
|
|
| Cat No. | CBS-V955 |
| Source | Pseudotyped lentivirus |
| Virus Name | SARS-CoV-2 |
| Virus Family | Coronaviridae |
| Composition | S; Null protein |
| Purity | 90% |
| Presentation | PBS |
| Description | It is the replication-incompetent particles in which the native, full-length COVID-19 S protein (with 6His-tag at its C-terminal) was pseudo-typed as the lentiviral particles’ surface envelope protein. The virus genome is not included. Instead it was replaced by a null sequence under CMV promoter. It is mock lentivirus. |
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
What expression systems do you use for your VLP products?
Our virus-like particles are produced from different expression systems such as E. coli, yeast, insect cells, and HEK293 cells.
